NEW YORK ─ Eurofins said on Tuesday that it has increased its revenue guidance for fiscal year 2020 to €5.3 billion ($6.44 billion), up from €5.0 billion established in March before COVID-19 disruptions started in Europe and North America.
The Luxembourg-based company said that in the second half of 2020, its core business, excluding COVID-19 clinical reagents and testing revenues, remained resilient, despite the impact of lockdowns in many geographies.